Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Stock Traders Daily
$20.00
Provider: S&P Capital IQ Quantitative Report
$92.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Abbott Laboratories Issues Q2 2013 EPS Guidance In Line With Analysts' Estimates; Reaffirms FY 2013 EPS Guidance


Wednesday, 17 Apr 2013 07:45am EDT 

Abbott Laboratories announced that for second quarter of 2013 it expects ongoing earnings per share (EPS) in the range of $0.43 to $0.45. The Company forecasts net specified items for the second quarter of 2013 of approximately $0.16 per share. Including these net specified items, projected earnings per share from continuing operations under Generally Accepted Accounting Principles (GAAP) would be $0.27 to $0.29. Specified items are primarily associated with intangible amortization expense and previously announced cost reduction initiatives. The Company reaffirmed fiscal 2013 EPS guidance and expects EPS in the range of $1.98 to $2.04. The Company forecasts net specified items for fiscal 2013 of approximately $0.59 per share. Including these net specified items, projected earnings per share from continuing operations under Generally Accepted Accounting Principles (GAAP) would be $1.39 to $1.45 for fiscal 2013. According to I/B/E/S Estimates, analysts were expecting the Company to report EPS of $0.44 for second quarter of 2013 and EPS of $2.01 for fiscal 2013. 

Company Quote

42.11
-0.21 -0.50%
22 Aug 2014